SCHEMBL20740318

SCHEMBL20740318

OCC(O)C(O)C(O)c1c[nH]c(C2=NOCC2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20740317 1.00
SCHEMBL1830663 0.70 L3MBTL1 (0.32)
SCHEMBL1604058 0.70 L3MBTL1 (0.32)
Water SCHEMBL1831822 0.69 L3MBTL1 (0.31)
Hydrochloric Acid SCHEMBL29571133 0.69 L3MBTL1 (0.31)
Lx-2931 SCHEMBL304963 0.65 L3MBTL1 (0.33)
Lx-2931 SCHEMBL20744226 0.65 L3MBTL1 (0.33)
Lx-2931 SCHEMBL20744228 0.65 L3MBTL1 (0.33)
Lx-2931 SCHEMBL316870 0.65 L3MBTL1 (0.33)
Lx-2931 SCHEMBL304964 0.65 L3MBTL1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11850234-B2 Enhancement of cancer treatment efficiency via the sphingosine-1-phosphate pathway AC BIOSCIENCE (CH) 2023-12-26 US disclosed
US-20200261420-A1 ENHANCEMENT OF CANCER TREATMENT EFFICIENCY VIA THE SPHINGOSINE-1-PHOSPHATE PATHWAY AC BIOSCIENCE (CH) 2020-08-20 US disclosed
EP-3668506-A1 ENHANCEMENT OF CANCER TREATMENT EFFICIENCY VIA THE SPHINGOSINE-1-PHOSPHATE PATHWAY AC BioScience (CH) 2020-06-24 EP disclosed
WO-2019034768-A1 ENHANCEMENT OF CANCER TREATMENT EFFICIENCY VIA THE SPHINGOSINE-1-PHOSPHATE PATHWAY AC BIOSCIENCE (CH) 2019-02-21 WO disclosed
EP-3443986-A1 ENHANCEMENT OF CHEMOTHERAPY EFFICIENCY BY SPHINGOSINE-1-PHOSPHATE AC BioScience (CH) 2019-02-20 EP disclosed